Discuss This Drug

ALDESLEUKIN

CHEBI:CHEBI_747947

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

nui
N0000175629
pharm_class_pe
Increased Lymphocyte Cell Production [PE]
pharm_class
Interferon-gamma [CS]
pharm_class_cs
Interferon-gamma [CS]
pharm_class_epc
Interferon gamma [EPC]
upc
0317089251200
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
SUS SCROFA PROSTATE
active_ingredient_strength
1.1 mg/1.1mg
unii
TKD8LH0X2Z
spl_set_id
8bf717eb-fe46-4066-b124-eb715ffc1542
generic_name
ALDESLEUKIN - BINETRAKIN - CANAKINUMAB - CENTELLA ASIATICA - CRANBERRY - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - LENOGRASTIM - PINEAPPLE - SUS SCROFA BONE MARROW - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA THYMUS -
rxcui
105648
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
INTRAVENOUS
package_marketing_start_date
06-JAN-15
dosage_form
PELLET
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
19920505
labeler_name
Clinigen Limited
manufacturer_name
Clinigen Limited
brand_name
GUNA-DERMO
brand_name_base
GUNA-DERMO
product_ndc
12714-213
spl_id
18fdd732-3a65-1839-e063-6394a90adb09
package_ndc
12714-213-11
package_description
1.3 mg in 1 VIAL, SINGLE-DOSE (12714-213-11)
application_number
BLA103293